CytoSorbents Corp (NAS:CTSO)
$ 0.8 0.0092 (1.16%) Market Cap: 43.45 Mil Enterprise Value: 51.95 Mil PE Ratio: 0 PB Ratio: 2.29 GF Score: 58/100

Q3 2021 Cytosorbents Corp Earnings Call Transcript

Nov 04, 2021 / 08:30PM GMT
Release Date Price: $6.11 (-0.16%)
Operator

Good afternoon, and welcome to the CytoSorbents' Third Quarter 2021 Financial and Operating Results Conference Call. (Operator Instructions) Please be advised that the call will be recorded at the company's request.

At this time, I'd like to turn the call over to our moderator, Terri Anne Powers, Vice President of Investor Relations and Corporate Communications. Please go ahead, Ms. Powers.

Terri Anne Powers
Cytosorbents Corporation - VP of IR & Corporate Communications

Thank you, Dave, and good afternoon and evening to everyone that is listening. Welcome to the CytoSorbents' Third Quarter 2021 Financial and Operating Results Call. Joining me today from the company are Dr. Phillip Chan, CytoSorbents' Chief Executive Officer; Vincent Capponi, our President and Chief Operating Officer; Kathleen Bloch, our Chief Financial Officer; Dr. Efthymios Makis Deliargyris, Chief Medical Officer; Dr. Christian Steiner, Executive Vice President of Sales and Marketing and also Managing Director of CytoSorbents Europe; and finally, Christopher Cramer, Vice

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot